Authors to be notified of abstract results by Monday 1 March
On behalf of the Local Organising Committee I have great
pleasure in inviting international researchers and their
companions to Melbourne, Australia in June/July, 2010 for
the 11th International Symposium on the Genetics of Industrial
Microorganisms, GIM2010.
GIM is an extra special meeting that occurs once every
four years and this will be the first time GIM has been
held in Australia. Therefore we are eager to offer our colleagues
hospitality and exhibit the beauty of our natural resources.
Melbourne is regarded as one of the top conference destinations
in the world and we hope that you will come to agree.
Thank you to those that have submitted an abstract for
the GIM 2010 Symposium. Authors will be notified of acceptance
by Monday 1 March 2010. Late abstract submissions authors
will be notified of results by Monday 15 March 2010.
STUDENT FUNDING APPLICATIONS NOW CLOSED
Thank you to those students who have submitted an application to be considered to receive a complimentary registration to attend GIM 2010. Students will be accepted based on specific criteria. Students will be notified of acceptance by Friday 26 February 2010.
This This month’s featured speaker is
Dr Alex Franzusoff. Dr Franzusoff will be a symposia speaker at GIM 2010.
Dr Alex Franzusoff
Dr Franzusoff has carried out cutting edge research in immunotherapy against cancer and infectious disease, as well as HIV virus assembly, secretory pathway function and engineering of recombinant yeast for the production of foreign proteins. In addition to co-inventing the Tarmogen technology, Dr. Franzusoff has authored more than 40 publications on immunotherapy against infectious diseases and cancer, yeast cell biology, HIV infectivity and recombinant DNA engineering.
Dr Franzusoff has carried out cutting edge research in immunotherapy against cancer and infectious disease, as well as HIV virus assembly, secretory pathway function and engineering of recombinant yeast for the production of foreign proteins. In addition to co-inventing the Tarmogen technology, Dr. Franzusoff has authored more than 40 publications on immunotherapy against infectious diseases and cancer, yeast cell biology, HIV infectivity and recombinant DNA engineering.
